Both selective AMYR agonists, and dual CTR and AMYR agonists such as sCT 5,6,7 , have demonstrated efficacy in controlling appetite and body weight, however this is not seen with a CTR-selective agonist 9
This transparency ensures that nothing interferes with your medical care while still allowing you to prioritize your long-term health
Franz, D
What has not changed is the underlying evidence base
More preclinical studies are needed to optimize iron metabolism regulation protocols in various iron overload conditions and to explore the best treatment strategies to reduce iron levels
61,62,63 CDO is highly regulated at the level of protein turnover, as oxidative degradation of cysteine by CDO is highly inducible, 64 and high cysteine levels inhibit CDO ubiquitinylation and reduce its proteasomal degradation